Shockwave, which now operates under J&J’s MedTech division, offers the market’s only intravascular lithotripsy platform for coronary artery disease and peripheral disease, according to a J&J news release.
The company has been steadily growing its cardiovascular line after buying Abiomed in 2022 for $16.6 billion and Laminar in late 2023 for $400 million. The latest acquisition has propelled J&J to be a “leader in four of the largest and highest-growth medtech markets within cardiovascular intervention,” the release said.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
